logo
Piper Sandler Reaffirms Price Target on Axsome (AXSM) Despite AXS-14 FDA Hurdle

Piper Sandler Reaffirms Price Target on Axsome (AXSM) Despite AXS-14 FDA Hurdle

Yahoo7 days ago
Axsome Therapeutics Inc. (NASDAQ:AXSM) ranks among the 30 stocks expected to beat the market by 20 percentage points this year. Piper Sandler analysts maintained their $148 price target for Axsome Therapeutics Inc. (NASDAQ:AXSM) and reaffirmed their Overweight rating on June 10. This decision comes after the company revealed that the FDA had sent it a Refuse to File (RTF) notice regarding its New Drug Application (NDA) for AXS-14, an oral norepinephrine reuptake inhibitor used to treat fibromyalgia.
Although Piper Sandler analysts acknowledged the setback, they stressed that Axsome's shares are not significantly impacted by this incident. Given the lack of new agent approvals in the fibromyalgia sector over the past ten years, the analysts pointed out that the FDA's requested additional study would be useful, and claim that Axsome Therapeutics Inc. (NASDAQ:AXSM) can support the new study with its current commercial infrastructure.
Axsome Therapeutics Inc. (NASDAQ:AXSM) is a clinical stage biopharmaceutical company that contributes to the creation of novel therapies for disorders of the central nervous system.
While we acknowledge the potential of AXSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
Read More: and
Disclosure: None.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ultragenyx falls 4% to $28.41 after FDA rejection letter for gene therapy
Ultragenyx falls 4% to $28.41 after FDA rejection letter for gene therapy

Business Insider

time28 minutes ago

  • Business Insider

Ultragenyx falls 4% to $28.41 after FDA rejection letter for gene therapy

17:19 EDT Ultragenyx (RARE) falls 4% to $28.41 after FDA rejection letter for gene therapy Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Kraft Heinz reportedly plans to split up, spin off grocery business
Kraft Heinz reportedly plans to split up, spin off grocery business

Yahoo

time38 minutes ago

  • Yahoo

Kraft Heinz reportedly plans to split up, spin off grocery business

-- Kraft Heinz (NASDAQ:KHC) Co is preparing to break itself up by spinning off a significant portion of its grocery business, according to a Wall Street Journal report published Friday. The food giant is looking to separate many Kraft products into a new standalone entity that could be valued at up to $20 billion, the report said, citing people familiar with the matter. Following the split, Kraft Heinz would retain its sauce and spread products, including the company's flagship Heinz ketchup and Grey Poupon Dijon mustard. Kraft Heinz shares are gaining over 2.5% following the publication of the WSJ report. Related articles Kraft Heinz reportedly plans to split up, spin off grocery business Air India crash probe reveals pilot cut fuel flow to engines S&P 500 falls after Pulte claims Powell considering resignation Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Dividends Declared During the Week of July 7
Dividends Declared During the Week of July 7

Yahoo

time38 minutes ago

  • Yahoo

Dividends Declared During the Week of July 7

Energy companies are gearing up for second-quarter 2025 earnings season. Here is a compilation of dividends declared during the week of July 7 from select midstream and service and supply companies. Targa Resources Targa Resources Corp. declared a quarterly cash dividend of $1 per common share, $4 per share annualized, for the second quarter of 2025. The cash dividend will be paid Aug. 15 on all outstanding common shares to holders of record as of the close of business on July 31. Pembina Pipeline Pembina Pipeline Corp. declared quarterly dividends for a series of preferred shares—Series 1, 3, 5, 7, 9, 15, 17, 21 and 25. Series 1, 3, 5, 7, 9 and 21 preferred share dividends are payable on Sept. 2 to shareholders of record on Aug. 1. Series 15 and 17 are payable on Oct. 1 to shareholders of record on Sept. 15. Series 25 preferred share dividends are payable on Aug. 15 to shareholders of record on July 31. NW Natural Energy infrastructure company Northwest Natural Holding Co. declared a quarterly dividend of $0.49 per share on July 10. The dividend will be paid on Aug. 15 to shareholders of record on July 31. NW Natural said its annual dividend rate is $1.96 per share. Phillips 66 Phillips 66 declared a quarterly dividend on July 10 for $1.20 per share on its common stock. The dividend is payable on Sept. 2 to shareholders of record as of Aug. 19. Emera North American energy services provider Emera Inc. declared quarterly dividends on July 11 on its common shares and first preferred shares. The common share dividend will be paid out as approximately $0.73 per share. The preferred share dividends will be paid out as follows: $0.1364 per Series A first preferred share; $0.2789 per Series B first preferred share; $0.40213 per Series C first preferred share; $0.28125 per Series E first preferred share; $0.35931 per Series F first preferred share; $0.39525 per Series H first preferred share; $0.265625 per Series J first preferred share; and $0.2875 per Series L first preferred share. The dividends are payable on and after Aug. 15 to shareholders of record as of Aug. 1.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store